Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a broccoli supplement slow kidney disease?

NCT ID NCT05797506

Completed Disease control Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a daily supplement called Avmacol Extra Strength, which contains sulforaphane from broccoli seeds, can slow kidney disease progression in people with stage 3 or 4 chronic kidney disease. The trial enrolled 96 adults and compared the supplement to a placebo over 6 months. Researchers measured changes in markers of inflammation and kidney function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
sulforaphane (from broccoli seed extract)
What this could lead to
If it works, this could point toward a simple dietary supplement to help slow kidney disease progression and reduce inflammation.
What could go wrong
This is a small, early-phase trial focused on safety and markers, not on hard outcomes like kidney failure. The supplement may not show clear benefit, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 4 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE STAGE 4 CHRONIC KIDNEY DISEASE, STAGE 3

Contacts and locations

Locations

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.